plerixafor

Generic: plerixafor

Labeler: meitheal pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name plerixafor
Generic Name plerixafor
Labeler meitheal pharmaceuticals inc.
Dosage Form SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

plerixafor 24 mg/1.2mL

Manufacturer
Meitheal Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 71288-155
Product ID 71288-155_bf37c037-175b-45cf-bed3-ced897418f28
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215698
Listing Expiration 2026-12-31
Marketing Start 2023-07-24

Pharmacologic Class

Established (EPC)
hematopoietic stem cell mobilizer [epc]
Physiologic Effect
increased hematopoietic stem cell mobilization [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71288155
Hyphenated Format 71288-155

Supplemental Identifiers

RxCUI
828700
UNII
S915P5499N
NUI
N0000178326 N0000178324

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name plerixafor (source: ndc)
Generic Name plerixafor (source: ndc)
Application Number ANDA215698 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 24 mg/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-155-01) / 1.2 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

plerixafor (24 mg/1.2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "bf37c037-175b-45cf-bed3-ced897418f28", "openfda": {"nui": ["N0000178326", "N0000178324"], "unii": ["S915P5499N"], "rxcui": ["828700"], "spl_set_id": ["646d87cd-e2e0-49cf-96e6-112701230969"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (71288-155-01)  / 1.2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "71288-155-01", "marketing_start_date": "20230724"}], "brand_name": "Plerixafor", "product_id": "71288-155_bf37c037-175b-45cf-bed3-ced897418f28", "dosage_form": "SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "71288-155", "generic_name": "Plerixafor", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plerixafor", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "ANDA215698", "marketing_category": "ANDA", "marketing_start_date": "20230724", "listing_expiration_date": "20261231"}